Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment

Summary

This is a research study to determine if administering carboplatin at a slower rate when re-treating recurrent ovarian cancer patients prior to the development of a hypersensitivity reaction will decrease the frequency and severity of future hypersensitivity reactions.

Timeline

Start

2014-01

Primary completion

2015-03

Completion

2016-06

Outcome

Outcome not reported

Stopped: “Extended Carboplatin Infusion did not Reduce Frequency of Hypersensitivity Reactions”

Drugs

Indications